Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 3
2014 4
2015 5
2016 4
2017 4
2019 2
2020 6
2021 6
2022 7
2023 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial.
Harrison CN, Nangalia J, Boucher R, Jackson A, Yap C, O'Sullivan J, Fox S, Ailts I, Dueck AC, Geyer HL, Mesa RA, Dunn WG, Nadezhdin E, Curto-Garcia N, Green A, Wilkins B, Coppell J, Laurie J, Garg M, Ewing J, Knapper S, Crowe J, Chen F, Koutsavlis I, Godfrey A, Arami S, Drummond M, Byrne J, Clark F, Mead-Harvey C, Baxter EJ, McMullin MF, Mead AJ. Harrison CN, et al. Among authors: geyer hl. J Clin Oncol. 2023 Jul 1;41(19):3534-3544. doi: 10.1200/JCO.22.01935. Epub 2023 May 1. J Clin Oncol. 2023. PMID: 37126762 Free PMC article. Clinical Trial.
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.
Emanuel RM, Dueck AC, Geyer HL, Kiladjian JJ, Slot S, Zweegman S, te Boekhorst PA, Commandeur S, Schouten HC, Sackmann F, Kerguelen Fuentes A, Hernández-Maraver D, Pahl HL, Griesshammer M, Stegelmann F, Doehner K, Lehmann T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto JC, Ranta D, Roy L, Cahn JY, Harrison CN, Radia D, Muxi P, Maldonado N, Besses C, Cervantes F, Johansson PL, Barbui T, Barosi G, Vannucchi AM, Passamonti F, Andreasson B, Ferrari ML, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Mesa RA. Emanuel RM, et al. Among authors: geyer hl. J Clin Oncol. 2012 Nov 20;30(33):4098-103. doi: 10.1200/JCO.2012.42.3863. Epub 2012 Oct 15. J Clin Oncol. 2012. PMID: 23071245 Free PMC article.
An Institutional Approach to Managing the Opioid Crisis.
Gazelka HM, Clements CM, Cunningham JL, Geyer HL, Lovely JK, Olson CL, Philpot LM, Porter SB, Witt TJ, Zavaleta KW, Habermann EB. Gazelka HM, et al. Among authors: geyer hl. Mayo Clin Proc. 2020 May;95(5):968-981. doi: 10.1016/j.mayocp.2019.11.019. Epub 2020 Mar 11. Mayo Clin Proc. 2020. PMID: 32171474 Review.
Emerging drugs for the treatment of myelofibrosis.
Geyer HL, Mesa RA. Geyer HL, et al. Expert Opin Emerg Drugs. 2015;20(4):663-78. doi: 10.1517/14728214.2015.1061502. Epub 2015 Jul 8. Expert Opin Emerg Drugs. 2015. PMID: 26153237 Review.
Quality of life in MPN comes of age as a therapeutic target.
Scherber RM, Geyer HL, Mesa RA. Scherber RM, et al. Among authors: geyer hl. Curr Hematol Malig Rep. 2014 Dec;9(4):324-30. doi: 10.1007/s11899-014-0239-9. Curr Hematol Malig Rep. 2014. PMID: 25262210 Review.
39 results